Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type |
A1 | 1 | 68 | M | Stomach | Adenocarcinoma | 3 | T3N1M0 | IIB | Malignant |
A2 | 2 | 55 | M | Stomach | Adenocarcinoma | 2 | T4N2M0 | IIIB | Malignant |
A3 | 3 | 64 | M | Stomach | Adenocarcinoma | 2 | T2N1M0 | IIA | Malignant |
A4 | 4 | 60 | M | Stomach | Adenocarcinoma | 1 | T4N0M0 | IIB | Malignant |
A5 | 5 | 66 | M | Stomach | Adenocarcinoma | 2 | T3N0M0 | IIA | Malignant |
A6 | 6 | 46 | F | Skin | Malignant melanoma of thigh | * | T4N1M0 | III | Malignant |
A7 | 7 | 37 | M | Skin | Malignant melanoma of right upper arm | * | T4N0M0 | IIB | Malignant |
A8 | 8 | 55 | M | Skin | Malignant melanoma of sole of foot | * | T4N0M0 | IIB | Malignant |
A9 | 9 | 54 | F | Skin | Malignant melanomaof right heel | * | T4N0M0 | IIB | Malignant |
A10 | 10 | 54 | M | Skin | Malignant melanoma of left index finger | * | T4N0M0 | IIB | Malignant |
A11 | 11 | 26 | M | Prostate | Adenocarcinoma (Gleason grade:4, Gleason score: 4+4) | 2 | T2N0M0 | IIA | Malignant |
A12 | 12 | 71 | M | Prostate | Adenocarcinoma (Gleason grade:3, Gleason score: 3+3) | 2 | T2N0M0 | IIA | Malignant |
A13 | 13 | 69 | M | Prostate | Adenocarcinoma (Gleason grade:3, Gleason score: 3+4) | 2 | T3N0M0 | III | Malignant |
A14 | 14 | 60 | M | Prostate | Adenocarcinoma (Gleason grade:4, Gleason score: 4+3) | 2 | T3N1M0 | IV | Malignant |
A15 | 15 | 75 | M | Prostate | Adenocarcinoma (Gleason grade:4, Gleason score: 4+4) | 3 | T2N0M0 | IIA | Malignant |
A16 | 16 | 41 | F | Cerebrum | Astrocytoma | 2 | * | * | Malignant |
A17 | 17 | 29 | M | Cerebrum | Astrocytoma | 2 | * | * | Malignant |
A18 | 18 | 22 | M | Cerebrum | Astrocytoma | 2 | * | * | Malignant |
A19 | 19 | 46 | F | Cerebrum | Astrocytoma | 2 | * | * | Malignant |
A20 | 20 | 49 | F | Cerebrum | Astrocytoma | 2 | * | * | Malignant |
A21 | 21 | 26 | F | Ovary | Low grade serous carcinoma | * | T1cN0M0 | IC | Malignant |
A22 | 22 | 38 | F | Ovary | Low grade serous carcinoma | * | T3cN1M0 | IIIC | Malignant |
A23 | 23 | 51 | F | Ovary | High grade serous carcinoma | * | T3cN1M0 | IIIC | Malignant |
A24 | 24 | 34 | F | Ovary | Low grade serous carcinoma | * | T1aN0M0 | IA | Malignant |
A25 | 25 | 34 | F | Ovary | Low grade serous carcinoma | * | T1bN0M0 | IB | Malignant |
B1 | 26 | 62 | F | Stomach | Adenocarcinoma | 2 | T2N0M0 | IB | Malignant |
B2 | 27 | 66 | M | Stomach | Adenocarcinoma | 2 | T3N0M0 | IIA | Malignant |
B3 | 28 | 47 | M | Stomach | Adenocarcinoma | 1 | T2N1M0 | IIA | Malignant |
B4 | 29 | 55 | M | Stomach | Adenocarcinoma | 3 | T3N0M0 | IIA | Malignant |
B5 | 30 | 56 | M | Stomach | Adenocarcinoma | 3 | T3N1M0 | IIB | Malignant |
B6 | 31 | 41 | M | Skin | Malignant melanoma of forearm | * | T4N0M0 | IIB | Malignant |
B7 | 32 | 25 | M | Skin | Malignant melanoma of left sole of foot | * | T2N0M0 | IB | Malignant |
B8 | 33 | 51 | M | Skin | Malignant melanoma of back | * | T4N0M0 | IIB | Malignant |
B9 | 34 | 77 | F | Skin | Malignant melanoma of left sole of foot | * | T4N0M0 | IIB | Malignant |
B10 | 35 | 42 | M | Skin | Malignant melanoma of left heel | * | T3N0M0 | IIA | Malignant |
B11 | 36 | 73 | M | Prostate | Adenocarcinoma (Gleason grade: 4, Gleason score: 4+4) | 2 | T3N0M0 | III | Malignant |
B12 | 37 | 60 | M | Prostate | Adenocarcinoma (Gleason grade: 5, Gleason score: 5+4) | 3 | T3N1M0 | IV | Malignant |
B13 | 38 | 64 | M | Prostate | Adenocarcinoma (Gleason grade: 3, Gleason score: 3+3) | 2 | T2N0M0 | IIA | Malignant |
B14 | 39 | 65 | M | Prostate | Adenocarcinoma (Gleason grade: 2, Gleason score: 2+2) | 1 | T2N0M0 | IIA | Malignant |
B15 | 40 | 82 | M | Prostate | Adenocarcinoma (Gleason grade: 4, Gleason score: 4+4) | 3 | T2N0M0 | IIA | Malignant |
B16 | 41 | 34 | F | Cerebrum | Astrocytoma | 2 | * | * | Malignant |
B17 | 42 | 50 | F | Cerebrum | Astrocytoma | 2 | * | * | Malignant |
B18 | 43 | 48 | M | Cerebrum | Astrocytoma | 2 | * | * | Malignant |
B19 | 44 | 51 | M | Cerebrum | Glioblastoma | 4 | * | * | Malignant |
B20 | 45 | 23 | M | Cerebrum | Glioblastoma | * | * | * | Malignant |
B21 | 46 | 58 | F | Ovary | High grade serous carcinoma | * | T1N0M0 | I | Malignant |
B22 | 47 | 47 | F | Ovary | High grade serous carcinoma | * | T1N0M0 | I | Malignant |
B23 | 48 | 48 | F | Ovary | High grade serous carcinoma | * | T1bN0M0 | IB | Malignant |
B24 | 49 | 57 | F | Ovary | High grade serous carcinoma | * | T3cN1M0 | IIIC | Malignant |
B25 | 50 | 42 | F | Ovary | High grade serous carcinoma | * | T2N0M0 | II | Malignant |
C1 | 51 | 53 | M | Stomach | Adenocarcinoma | 3 | T3N0M0 | IIA | Malignant |
C2 | 52 | 48 | M | Stomach | Adenocarcinoma | 3 | T3N1M0 | IIB | Malignant |
C3 | 53 | 69 | M | Stomach | Adenocarcinoma | 2 | T3N0M0 | IIA | Malignant |
C4 | 54 | 46 | M | Stomach | Adenocarcinoma | 3 | T3N2M0 | IIIA | Malignant |
C5 | 55 | 53 | M | Stomach | Adenocarcinoma | 3 | T3N0M0 | IIA | Malignant |
C6 | 56 | 52 | M | Skin | Malignant melanoma of abdominal part | * | T4N0M0 | IIB | Malignant |
C7 | 57 | 60 | M | Skin | Malignant melanoma of right buttock | * | T4N1M0 | III | Malignant |
C8 | 58 | 46 | F | Skin | Malignant melanoma of hallux | * | T4N0M0 | IIB | Malignant |
C9 | 59 | 41 | F | Skin | Malignant melanoma of groin | * | T4N0M0 | IIB | Malignant |
C10 | 60 | 69 | M | Skin | Malignant melanoma of sole of foot | * | T2N0M0 | IB | Malignant |
C11 | 61 | 62 | M | Prostate | Adenocarcinoma (Gleason grade: 4, Gleason score: 4+4) | 3 | T3N0M0 | III | Malignant |
C12 | 62 | 66 | M | Prostate | Adenocarcinoma (Gleason grade: 4, Gleason score: 4+4) | 3 | T3N0M0 | III | Malignant |
C13 | 63 | 64 | M | Prostate | Adenocarcinoma (Gleason grade: 3, Gleason score: 3+3) | 2 | T2N0M0 | IIA | Malignant |
C14 | 64 | 57 | M | Prostate | Adenocarcinoma (Gleason grade: 4, Gleason score: 4+3) | 2 | T2N0M0 | IIA | Malignant |
C15 | 65 | 70 | M | Prostate | Adenocarcinoma (Gleason grade: 4, Gleason score: 4+4) | 3 | T3N0M0 | III | Malignant |
C16 | 66 | 17 | M | Cerebrum | Glioblastoma | 4 | * | * | Malignant |
C17 | 67 | 37 | F | Cerebrum | Glioblastoma | 4 | * | * | Malignant |
C18 | 68 | 52 | M | Cerebrum | Glioblastoma | 4 | * | * | Malignant |
C19 | 69 | 18 | F | Cerebrum | Glioblastoma | 3 | * | * | Malignant |
C20 | 70 | 35 | M | Cerebrum | Glioblastoma | * | * | * | Malignant |
C21 | 71 | 55 | F | Ovary | High grade serous carcinoma | * | T1aN0M0 | IA | Malignant |
C22 | 72 | 46 | F | Ovary | High grade serous carcinoma | 2 | T2cN1M0 | IIIC | Malignant |
C23 | 73 | 49 | F | Ovary | Mucinous adenocarcinoma | 2 | T1aN0M0 | IA | Malignant |
C24 | 74 | 52 | F | Ovary | Mucinous adenocarcinoma | 2 | T1bN0M0 | IB | Malignant |
C25 | 75 | 46 | F | Ovary | Mucinous papillary adenocarcinoma | 1 | T1aN0M0 | IA | Malignant |
D1 | 76 | 58 | M | Stomach | Adenocarcinoma | 3 | T3N0M0 | IIA | Malignant |
D2 | 77 | 30 | M | Stomach | Adenocarcinoma | 2 | T3N0M0 | IIA | Malignant |
D3 | 78 | 67 | M | Stomach | Adenocarcinoma | 3 | T3N0M0 | IIA | Malignant |
D4 | 79 | 43 | M | Stomach | Adenocarcinoma | 3 | T3N1M0 | IIB | Malignant |
D5 | 80 | 55 | F | Stomach | Adenocarcinoma | 3 | T3N2M0 | IIIA | Malignant |
D6 | 81 | 69 | F | Rectum | Malignant melanoma | * | * | * | Malignant |
D7 | 82 | 84 | F | Rectum | Malignant melanoma | * | * | * | Malignant |
D8 | 83 | 64 | M | Rectum | Malignant melanoma | * | * | * | Malignant |
D9 | 84 | 52 | F | Rectum | Malignant melanoma | * | * | * | Malignant |
D10 | 85 | 57 | M | Rectum | Malignant melanoma | * | * | * | Malignant |
D11 | 86 | 80 | M | Prostate | Adenocarcinoma (Gleason grade: 4, Gleason score: 4+4) | 3 | T3N0M0 | III | Malignant |
D12 | 87 | 82 | M | Prostate | Adenocarcinoma (Gleason grade: 5, Gleason score: 4+5) | 3 | T2N0M0 | IIA | Malignant |
D13 | 88 | 76 | M | Prostate | Adenocarcinoma (Gleason grade: 5, Gleason score: 5+4) | 3 | T3N0M0 | III | Malignant |
D14 | 89 | 68 | M | Prostate | Adenocarcinoma (Gleason grade: 5, Gleason score: 5+5) | 3 | T2N0M0 | IIA | Malignant |
D15 | 90 | 63 | M | Prostate | Adenocarcinoma (Gleason grade: 5, Gleason score: 4+5) | 3 | T2N0M0 | IIA | Malignant |
D16 | 91 | 53 | M | Cerebrum | Glioblastoma | 3 | * | * | Malignant |
D17 | 92 | 9 | M | Cerebrum | Glioblastoma | 3 | * | * | Malignant |
D18 | 93 | 59 | F | Cerebrum | Glioblastoma | 3 | * | * | Malignant |
D19 | 94 | 59 | M | Cerebrum | Glioblastoma | 3 | * | * | Malignant |
D20 | 95 | 59 | M | Cerebrum | Glioblastoma | 4 | * | * | Malignant |
D21 | 96 | 48 | F | Ovary | Mucinous adenocarcinoma | 1 | T1bN0M0 | IB | Malignant |
D22 | 97 | 65 | F | Ovary | Adenocarcinoma | 1 | T2aN0M0 | IIA | Malignant |
D23 | 98 | 29 | F | Ovary | Adenocarcinoma | 1 | T3N0M0 | III | Malignant |
D24 | 99 | 41 | F | Ovary | Adenocarcinoma | 3 | T1bN0M0 | IB | Malignant |
D25 | 100 | 22 | F | Ovary | Teilum tumor | * | T1cN0M0 | IC | Malignant |
E1 | 101 | 21 | M | Stomach | Stomach mucosa tissue | * | * | * | Normal |
E2 | 102 | 50 | M | Stomach | Stomach mucosa tissue | * | * | * | Normal |
E3 | 103 | 30 | M | Stomach | Stomach mucosa tissue | * | * | * | Normal |
E4 | 104 | 15 | F | Stomach | Stomach mucosa tissue | * | * | * | Normal |
E5 | 105 | 32 | M | Stomach | Stomach mucosa tissue | * | * | * | Normal |
E6 | 106 | 22 | M | Skin | Skin tissue | * | * | * | Normal |
E7 | 107 | 30 | M | Skin | Skin tissue of neck | * | * | * | Normal |
E8 | 108 | 45 | M | Skin | Skin tissue | * | * | * | Normal |
E9 | 109 | 40 | M | Skin | Skin tissue | * | * | * | Normal |
E10 | 110 | 40 | M | Skin | Skin tissue | * | * | * | Normal |
E11 | 111 | 32 | M | Prostate | Prostate tissue | * | * | * | Normal |
E12 | 112 | 35 | M | Prostate | Prostate tissue | * | * | * | Normal |
E13 | 113 | 35 | M | Prostate | Prostate tissue | * | * | * | Normal |
E14 | 114 | 38 | M | Prostate | Prostate tissue | * | * | * | Normal |
E15 | 115 | 43 | M | Prostate | Prostate tissue | * | * | * | Normal |
E16 | 116 | 26 | M | Cerebrum | Cerebrum tissue | * | * | * | Normal |
E17 | 117 | 42 | F | Cerebrum | Cerebrum tissue | * | * | * | Normal |
E18 | 118 | 38 | F | Cerebrum | Cerebrum tissue | * | * | * | Normal |
E19 | 119 | 50 | F | Cerebrum | Cerebrum tissue | * | * | * | Normal |
E20 | 120 | 2 | F | Cerebrum | Cerebrum tissue | * | * | * | Normal |
E21 | 121 | 45 | F | Ovary | Adjacent normal ovary tissue | * | * | * | NAT |
E22 | 122 | 45 | F | Ovary | Adjacent normal ovary tissue | * | * | * | NAT |
E23 | 123 | 38 | F | Ovary | Adjacent normal ovary tissue | * | * | * | NAT |
E24 | 124 | 45 | F | Ovary | Adjacent normal ovary tissue | * | * | * | NAT |
E25 | 125 | 62 | F | Ovary | Adjacent normal ovary tissue | * | * | * | NAT |
F1 | 126 | 51 | F | Breast | Invasive carcinoma of no special type | 1 | T2N2M0 | IIIA | Malignant |
F2 | 127 | 48 | F | Breast | Invasive carcinoma of no special type | 1 | T4N2M0 | IIIB | Malignant |
F3 | 128 | 69 | F | Breast | Invasive carcinoma of no special type | 1 | T2N1M0 | IIB | Malignant |
F4 | 129 | 55 | F | Breast | Invasive carcinoma of no special type | 2 | T2N0M0 | IIA | Malignant |
F5 | 130 | 43 | F | Breast | Invasive carcinoma of no special type | 2 | T3N0M0 | IIB | Malignant |
F6 | 131 | 30 | M | Testis | Seminoma | * | T1N0M0 | I | Malignant |
F7 | 132 | 52 | M | Testis | Seminoma | * | T2N0M0 | I | Malignant |
F8 | 133 | 36 | M | Testis | Seminoma | * | T2N0M0 | I | Malignant |
F9 | 134 | 70 | M | Testis | Seminoma | * | T1N0M0 | I | Malignant |
F10 | 135 | 31 | M | Testis | Seminoma | * | T1N0M0 | I | Malignant |
F11 | 136 | 58 | M | Colon | Adenocarcinoma | 1 | T3N1M0 | IIIB | Malignant |
F12 | 137 | 27 | M | Colon | Adenocarcinoma | 1 | T4N0M0 | IIB | Malignant |
F13 | 138 | 35 | M | Colon | Adenocarcinoma | 1 | T4N1M0 | IIIB | Malignant |
F14 | 139 | 44 | M | Colon | Adenocarcinoma | 3 | T4N1M0 | IIIB | Malignant |
F15 | 140 | 65 | F | Colon | Adenocarcinoma | 2 | T3N0M0 | IIA | Malignant |
F16 | 141 | 56 | M | Bladder | Urothelial carcinoma | * | T2N0M0 | II | Malignant |
F17 | 142 | 45 | M | Bladder | Urothelial carcinoma | * | T1N0M0 | I | Malignant |
F18 | 143 | 63 | M | Bladder | Urothelial carcinoma | * | T2N0M0 | II | Malignant |
F19 | 144 | 53 | M | Bladder | Urothelial carcinoma | * | T3N0M0 | III | Malignant |
F20 | 145 | 42 | M | Bladder | Urothelial carcinoma | * | T2N0M0 | II | Malignant |
F21 | 146 | 66 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1N0M0 | I | Malignant |
F22 | 147 | 34 | F | Uterus | Endometrioid adenocarcinoma | 1 | T2aN0M0 | II | Malignant |
F23 | 148 | 51 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant |
F24 | 149 | 42 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1N0M0 | I | Malignant |
F25 | 150 | 58 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant |
G1 | 151 | 52 | F | Breast | Invasive carcinoma of no special type | 2 | T3N0M0 | IIB | Malignant |
G2 | 152 | 64 | F | Breast | Invasive carcinoma of no special type | 2 | T2N0M0 | IIA | Malignant |
G3 | 153 | 34 | F | Breast | Invasive carcinoma of no special type | 3 | T2N0M0 | IIA | Malignant |
G4 | 154 | 52 | F | Breast | Invasive carcinoma of no special type | 2 | T2N2M0 | IIIA | Malignant |
G5 | 155 | 45 | F | Breast | Invasive carcinoma of no special type | 2 | T2N0M0 | IIA | Malignant |
G6 | 156 | 45 | M | Testis | Seminoma | * | T1N0M0 | I | Malignant |
G7 | 157 | 55 | M | Testis | Seminoma | * | T1N0M0 | I | Malignant |
G8 | 158 | 30 | M | Testis | Seminoma | * | T1N0M0 | I | Malignant |
G9 | 159 | 52 | M | Testis | Seminoma | * | T2N0M0 | I | Malignant |
G10 | 160 | 55 | M | Testis | Seminoma | * | T2N0M0 | I | Malignant |
G11 | 161 | 52 | F | Colon | Adenocarcinoma | 1 | T3N0M0 | IIA | Malignant |
G12 | 162 | 44 | M | Colon | Adenocarcinoma | 1 | T4N0M0 | IIB | Malignant |
G13 | 163 | 33 | F | Colon | Adenocarcinoma | 1 | T4N0M0 | IIB | Malignant |
G14 | 164 | 39 | M | Colon | Adenocarcinoma | 1 | T4N0M0 | IIB | Malignant |
G15 | 165 | 75 | M | Colon | Adenocarcinoma | 1 | T4N0M0 | IIB | Malignant |
G16 | 166 | 57 | M | Bladder | Urothelial carcinoma | * | T1N0M0 | I | Malignant |
G17 | 167 | 76 | M | Bladder | Urothelial carcinoma | * | T3N0M0 | III | Malignant |
G18 | 168 | 54 | F | Bladder | Urothelial carcinoma | * | T3N0M0 | III | Malignant |
G19 | 169 | 64 | M | Bladder | Urothelial carcinoma | * | T1N0M0 | I | Malignant |
G20 | 170 | 64 | F | Bladder | Urothelial carcinoma | * | T2N0M0 | II | Malignant |
G21 | 171 | 60 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant |
G22 | 172 | 62 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1cN1M0 | IIIC | Malignant |
G23 | 173 | 60 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1aN1M0 | IIIC | Malignant |
G24 | 174 | 55 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant |
G25 | 175 | 42 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant |
H1 | 176 | 68 | F | Breast | Invasive carcinoma of no special type | 2 | T2N0M0 | IIA | Malignant |
H2 | 177 | 42 | F | Breast | Invasive carcinoma of no special type | 1 | T3N0M0 | IIB | Malignant |
H3 | 178 | 53 | F | Breast | Invasive carcinoma of no special type | 2 | T2N0M0 | IIA | Malignant |
H4 | 179 | 52 | F | Breast | Invasive carcinoma of no special type | 2 | T2N1M0 | IIB | Malignant |
H5 | 180 | 49 | F | Breast | Invasive carcinoma of no special type | 2 | T2N0M0 | IIA | Malignant |
H6 | 181 | 33 | M | Testis | Seminoma | * | T1N0M0 | I | Malignant |
H7 | 182 | 39 | M | Testis | Seminoma | * | T2N0M0 | I | Malignant |
H8 | 183 | 35 | M | Testis | Seminoma | * | T4N0M0 | I | Malignant |
H9 | 184 | 34 | M | Testis | Seminoma | * | T1N0M0 | I | Malignant |
H10 | 185 | 39 | M | Testis | Seminoma | * | T1N0M0 | I | Malignant |
H11 | 186 | 52 | M | Colon | Adenocarcinoma | 1 | T3N1M0 | IIIB | Malignant |
H12 | 187 | 50 | M | Colon | Adenocarcinoma | 2 | T4N0M0 | IIB | Malignant |
H13 | 188 | 61 | M | Colon | Adenocarcinoma | 2 | T4N0M0 | IIB | Malignant |
H14 | 189 | 53 | M | Colon | Adenocarcinoma | 2 | T3N0M0 | IIA | Malignant |
H15 | 190 | 76 | F | Colon | Adenocarcinoma | 2 | T2N0M0 | I | Malignant |
H16 | 191 | 66 | M | Bladder | Urothelial carcinoma | * | T1N0M0 | I | Malignant |
H17 | 192 | 60 | M | Bladder | Urothelial carcinoma | * | T3N0M0 | III | Malignant |
H18 | 193 | 61 | F | Bladder | Urothelial carcinoma | * | T3N0M0 | III | Malignant |
H19 | 194 | 70 | M | Bladder | Urothelial carcinoma | * | T1N0M0 | I | Malignant |
H20 | 195 | 60 | F | Bladder | Urothelial carcinoma | * | T3N0M0 | III | Malignant |
H21 | 196 | 61 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant |
H22 | 197 | 43 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1aN0M0 | I | Malignant |
H23 | 198 | 54 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant |
H24 | 199 | 50 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant |
H25 | 200 | 58 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant |
I1 | 201 | 63 | F | Breast | Invasive carcinoma of no special type | 2--3 | T2N0M0 | IIA | Malignant |
I2 | 202 | 35 | F | Breast | Invasive carcinoma of no special type | 2--3 | T2N0M0 | IIA | Malignant |
I3 | 203 | 51 | F | Breast | Invasive carcinoma of no special type | 3 | T2N2M0 | IIIA | Malignant |
I4 | 204 | 60 | F | Breast | Invasive carcinoma of no special type with necrosis | 3 | T2N2M0 | IIIA | Malignant |
I5 | 205 | 55 | F | Breast | Invasive carcinoma of no special type | 3 | T2N0M0 | IIA | Malignant |
I6 | 206 | 21 | M | Testis | Embryonal carcinoma | * | T2N0M0 | I | Malignant |
I7 | 207 | 30 | M | Testis | Embryonal carcinoma | * | T2N0M0 | I | Malignant |
I8 | 208 | 23 | M | Testis | Embryonal carcinoma | * | T1N0M0 | I | Malignant |
I9 | 209 | 36 | M | Testis | Embryonal carcinoma | * | T1N0M0 | I | Malignant |
I10 | 210 | 28 | M | Testis | Embryonal carcinoma | * | T1N0M0 | I | Malignant |
I11 | 211 | 72 | F | Colon | Adenocarcinoma | 2 | T4N1M0 | IIIB | Malignant |
I12 | 212 | 66 | M | Colon | Adenocarcinoma | 2 | T3N0M0 | IIA | Malignant |
I13 | 213 | 48 | M | Colon | Adenocarcinoma | 2--3 | T2N1M0 | IIIA | Malignant |
I14 | 214 | 43 | F | Colon | Adenocarcinoma | 3 | T3N1M0 | IIIB | Malignant |
I15 | 215 | 47 | F | Colon | Adenocarcinoma | 3 | T3N2N0 | IIIB | Malignant |
I16 | 216 | 58 | F | Bladder | Urothelial carcinoma | * | T2N0M0 | II | Malignant |
I17 | 217 | 40 | M | Bladder | Urothelial carcinoma | * | T2N0M0 | II | Malignant |
I18 | 218 | 74 | F | Bladder | Urothelial carcinoma | * | T2N0M0 | II | Malignant |
I19 | 219 | 54 | F | Bladder | Urothelial carcinoma | * | T3N0M0 | III | Malignant |
I20 | 220 | 46 | M | Bladder | Urothelial carcinoma | * | T2N0M0 | II | Malignant |
I21 | 221 | 62 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1N0M0 | I | Malignant |
I22 | 222 | 68 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1bN0M0 | IB | Malignant |
I23 | 223 | 55 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1bN0M0 | IB | Malignant |
I24 | 224 | 77 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1bN0M0 | IB | Malignant |
I25 | 225 | 35 | F | Uterus | Endometrioid adenocarcinoma | 3--4 | T3aN0M0 | IIIA | Malignant |
J1 | 226 | 41 | F | Breast | Adjacent normal breast tissue | * | * | * | NAT |
J2 | 227 | 42 | F | Breast | Adjacent normal breast tissue | * | * | * | NAT |
J3 | 228 | 35 | F | Breast | Cancer adjacent breast tissue | * | * | * | AT |
J4 | 229 | 46 | F | Breast | Adjacent normal breast tissue | * | * | * | NAT |
J5 | 230 | 77 | F | Breast | Cancer adjacent breast tissue | * | * | * | AT |
J6 | 231 | 33 | M | Testis | Testis tissue | * | * | * | Normal |
J7 | 232 | 45 | M | Testis | Testis tissue | * | * | * | Normal |
J8 | 233 | 30 | M | Testis | Testis tissue | * | * | * | Normal |
J9 | 234 | 30 | M | Testis | Testis tissue | * | * | * | Normal |
J10 | 235 | 45 | M | Testis | Testis tissue | * | * | * | Normal |
J11 | 236 | 33 | M | Colon | Colon tissue | * | * | * | Normal |
J12 | 237 | 28 | M | Colon | Colon tissue | * | * | * | Normal |
J13 | 238 | 30 | M | Colon | Colon tissue | * | * | * | Normal |
J14 | 239 | 38 | M | Colon | Colon tissue | * | * | * | Normal |
J15 | 240 | 21 | F | Colon | Colon tissue | * | * | * | Normal |
J16 | 241 | 50 | M | Bladder | Bladder tissue | * | * | * | Normal |
J17 | 242 | 22 | M | Bladder | Bladder tissue | * | * | * | Normal |
J18 | 243 | 16 | F | Bladder | Bladder tissue | * | * | * | Normal |
J19 | 244 | 40 | F | Bladder | Bladder tissue | * | * | * | Normal |
J20 | 245 | 21 | F | Bladder | Bladder tissue | * | * | * | Normal |
J21 | 246 | 18 | F | Uterus | Endometrium tissue | * | * | * | Normal |
J22 | 247 | 36 | F | Uterus | Adjacent endometrium tissue | * | * | * | NAT |
J23 | 248 | 21 | F | Uterus | Endometrium tissue | * | * | * | Normal |
J24 | 249 | 21 | F | Uterus | Endometrium tissue | * | * | * | Normal |
J25 | 250 | 40 | F | Uterus | Adjacent endometrium tissue | * | * | * | NAT |
K1 | 251 | 56 | F | Thyroid gland | Papillary carcinoma | * | T2N0M0 | II | Malignant |
K2 | 252 | 33 | F | Thyroid gland | Papillary carcinoma | * | T1N0M0 | I | Malignant |
K3 | 253 | 25 | M | Thyroid gland | Papillary carcinoma | * | T1N0M0 | I | Malignant |
K4 | 254 | 56 | F | Thyroid gland | Papillary carcinoma | * | T2N0M0 | II | Malignant |
K5 | 255 | 55 | F | Thyroid gland | Papillary carcinoma | * | T2N0M0 | II | Malignant |
K6 | 256 | 69 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant |
K7 | 257 | 50 | M | Lung | Squamous cell carcinoma | 2 | T4N1M0 | IIIA | Malignant |
K8 | 258 | 58 | M | Lung | Squamous cell carcinoma | 2 | T2N1M0 | IIA | Malignant |
K9 | 259 | 68 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant |
K10 | 260 | 64 | M | Lung | Squamous cell carcinoma | 2 | T3N1M0 | IIA | Malignant |
K11 | 261 | 68 | M | Palate | Squamous cell carcinoma of right palate | 1 | T2N0M0 | II | Malignant |
K12 | 262 | 90 | M | Cheek | Squamous cell carcinoma | 1 | T2N0M0 | II | Malignant |
K13 | 263 | 74 | M | Lip | Squamous cell carcinoma of lower lip | 1 | T1N0M0 | I | Malignant |
K14 | 264 | 66 | M | Lip | Squamous cell carcinoma of lower lip | 1 | T2N0M0 | II | Malignant |
K15 | 265 | 80 | M | Lip | Squamous cell carcinoma of lower lip | 1 | T1N0M0 | I | Malignant |
K16 | 266 | 37 | F | Lymph node | Hodgkin‘s+lymphoma+of+right+neck | * | * | * | Malignant |
K17 | 267 | 32 | M | Lymph node | Hodgkin‘s+lymphoma+of+neck | * | * | * | Malignant |
K18 | 268 | 27 | M | Lymph node | Hodgkin‘s+lymphoma+of+neck | * | * | * | Malignant |
K19 | 269 | 34 | M | Lymph node | Hodgkin‘s+lymphoma+of+right+neck | * | * | * | Malignant |
K20 | 270 | 41 | M | Lymph node | Hodgkin‘s+lymphoma+of+neck | * | * | * | Malignant |
K21 | 271 | 52 | M | Thigh | Fibrosarcoma of left thigh | * | T1bN0M0 | IA | Malignant |
K22 | 272 | 36 | M | Chest wall | Fibrosarcoma | * | T2aN0M0 | IB | Malignant |
K23 | 273 | 25 | F | Waist | Fibrosarcoma of right waist | * | T2bN0M0 | IB | Malignant |
K24 | 274 | 38 | F | Chest wall | Fibrosarcoma of left chest wall | * | T1bN0M0 | IA | Malignant |
K25 | 275 | 60 | F | Abdomen | Fibrosarcoma | * | T2bN0M0 | IB | Malignant |
L1 | 276 | 67 | M | Thyroid gland | Papillary carcinoma | * | T2N0M0 | II | Malignant |
L2 | 277 | 28 | F | Thyroid gland | Papillary carcinoma | * | T2N0M0 | I | Malignant |
L3 | 278 | 26 | F | Thyroid gland | Papillary carcinoma | * | T2N0M0 | I | Malignant |
L4 | 279 | 30 | F | Thyroid gland | Papillary carcinoma | * | T2N0M0 | I | Malignant |
L5 | 280 | 40 | F | Thyroid gland | Papillary carcinoma | * | T2N0M0 | I | Malignant |
L6 | 281 | 65 | M | Lung | Squamous cell carcinoma | 3 | T4N0M0 | IIIA | Malignant |
L7 | 282 | 52 | M | Lung | Squamous cell carcinoma | 3 | T2N1M0 | IIA | Malignant |
L8 | 283 | 35 | F | Lung | Squamous cell carcinoma | 3 | T4N1M0 | IIIA | Malignant |
L9 | 284 | 68 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant |
L10 | 285 | 50 | F | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant |
L11 | 286 | 75 | F | Tongue | Squamous cell carcinoma | 1 | T2N0M0 | II | Malignant |
L12 | 287 | 66 | M | Tongue | Squamous cell carcinoma | 1 | T2N0M0 | II | Malignant |
L13 | 288 | 72 | M | Nasopharynx | Squamous cell carcinoma of nasopharynx | 1 | T1N0M0 | I | Malignant |
L14 | 289 | 65 | M | Tongue | Squamous cell carcinoma | 1 | T3N0M0 | II | Malignant |
L15 | 290 | 49 | M | Cheek | Squamous cell carcinoma of left cheek | 2 | T1N0M0 | I | Malignant |
L16 | 291 | 36 | M | Lymph node | Hodgkin‘s+lymphoma+of+left+groin | * | * | * | Malignant |
L17 | 292 | 17 | M | Lymph node | Hodgkin‘s+lymphoma+of+right+neck | * | * | * | Malignant |
L18 | 293 | 24 | M | Lymph node | Hodgkin‘s+lymphoma+of+neck | * | * | * | Malignant |
L19 | 294 | 3 | M | Lymph node | Hodgkin‘s+lymphoma+of+right+neck | * | * | * | Malignant |
L20 | 295 | 50 | M | Lymph node | Hodgkin‘s+lymphoma+of+right+armpit | * | * | * | Malignant |
L21 | 296 | 18 | M | Arm | Fibrosarcoma of right upper arm | * | T1bN0M0 | IA | Malignant |
L22 | 297 | 24 | F | Armpit | Fibrosarcoma of right armpit | * | T1aN0M0 | IA | Malignant |
L23 | 298 | 32 | M | Groin | Fibrosarcoma of left groin | * | T1bN0M0 | IA | Malignant |
L24 | 299 | 39 | F | Leg | Fibrosarcoma of left leg | * | T1N0M0 | IA | Malignant |
L25 | 300 | 27 | F | Abdomen | Fibrosarcoma of right abdominal part | * | T2aN0M0 | IB | Malignant |
M1 | 301 | 36 | F | Thyroid gland | Follicular carcinoma | * | T3N0M0 | I | Malignant |
M2 | 302 | 62 | M | Thyroid gland | Follicular carcinoma | * | T2N0M0 | II | Malignant |
M3 | 303 | 63 | F | Thyroid gland | Follicular carcinoma | * | T4N0M0 | IV | Malignant |
M4 | 304 | 46 | F | Thyroid gland | Follicular carcinoma | * | T1N0M0 | I | Malignant |
M5 | 305 | 60 | F | Thyroid gland | Follicular carcinoma | * | T1N0M0 | I | Malignant |
M6 | 306 | 59 | M | Lung | Adenocarcinoma | 3 | T2N1M0 | IIA | Malignant |
M7 | 307 | 55 | M | Lung | Adenocarcinoma | 2 | T1N0M0 | IA | Malignant |
M8 | 308 | 65 | M | Lung | Adenocarcinoma | 2 | T2N1M0 | IIA | Malignant |
M9 | 309 | 68 | M | Lung | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant |
M10 | 310 | 39 | F | Lung | Adenocarcinoma | 3 | T2N1M0 | IIA | Malignant |
M11 | 311 | 41 | M | Lip | Squamous cell carcinoma of lower lip | 2 | T3N0M0 | III | Malignant |
M12 | 312 | 50 | F | Tongue | Squamous cell carcinoma of root of tongue | 2 | T1N0M0 | I | Malignant |
M13 | 313 | 61 | M | Tongue | Squamous cell carcinoma | 2 | T2N0M0 | II | Malignant |
M14 | 314 | 47 | M | Nose | Squamous cell carcinoma of sinus | 2 | T2N0M0 | II | Malignant |
M15 | 315 | 63 | F | Nose | Squamous cell carcinoma of nasal cavity | 2 | T3N0M0 | III | Malignant |
M16 | 316 | 48 | F | Lymph node | Diffuse B cell lymphoma of right groin | * | * | * | Malignant |
M17 | 317 | 74 | M | Lymph node | Diffuse B cell lymphoma of left popliteal fossa | * | * | * | Malignant |
M18 | 318 | 51 | M | Lymph node | Diffuse B cell lymphoma of left neck | * | * | * | Malignant |
M19 | 319 | 29 | F | Lymph node | Diffuse B cell lymphoma of left armpit | * | * | * | Malignant |
M20 | 320 | 59 | M | Lymph node | Diffuse B cell lymphoma of neck | * | * | * | Malignant |
M21 | 321 | 42 | F | Thigh | Well-differentiated liposarcoma of left thigh | * | T2aN0M0 | IB | Malignant |
M22 | 322 | 58 | M | Thigh | Well-differentiated liposarcoma of right thigh | * | T2aN0M0 | IB | Malignant |
M23 | 323 | 72 | M | Thigh | Well-differentiated liposarcoma of right thigh | * | T1N0M0 | IA | Malignant |
M24 | 324 | 62 | M | Back | Well-differentiated liposarcoma of back | * | T2aN0M0 | IB | Malignant |
M25 | 325 | 36 | F | Retroperitoneal cavity | Well-differentiated liposarcoma | * | T2aN0M0 | IB | Malignant |
N1 | 326 | 75 | F | Thyroid gland | Follicular carcinoma | * | T4N0M0 | IV | Malignant |
N2 | 327 | 48 | F | Thyroid gland | Follicular carcinoma | * | T2N0M0 | II | Malignant |
N3 | 328 | 68 | F | Thyroid gland | Follicular carcinoma | * | T3N1M0 | III | Malignant |
N4 | 329 | 26 | F | Thyroid gland | Follicular carcinoma | * | T2N0M0 | II | Malignant |
N5 | 330 | 48 | F | Thyroid gland | Follicular carcinoma | * | T1N0M0 | I | Malignant |
N6 | 331 | 31 | M | Lung | Adenocarcinoma | 3 | T2N1M0 | IIA | Malignant |
N7 | 332 | 67 | M | Lung | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant |
N8 | 333 | 70 | M | Lung | Adenocarcinoma | 3 | T1N0M0 | IA | Malignant |
N9 | 334 | 74 | M | Lung | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant |
N10 | 335 | 46 | F | Lung | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant |
N11 | 336 | 69 | F | Cheek | Squamous cell carcinoma of right cheek | 1 | T2N0M0 | II | Malignant |
N12 | 337 | 56 | M | Tongue | Squamous cell carcinoma | 2 | T2N1M0 | III | Malignant |
N13 | 338 | 54 | M | Oral cavity | Squamous cell carcinoma of left upper jaw | 2 | T3N0M0 | III | Malignant |
N14 | 339 | 45 | M | Oral cavity | Squamous cell carcinoma of maxillary sinus | 3 | T3N0M0 | III | Malignant |
N15 | 340 | 49 | M | Gingiva | Squamous cell carcinoma | 3 | T2N0M0 | II | Malignant |
N16 | 341 | 45 | F | Lymph node | Diffuse B cell lymphoma of left armpit | * | * | * | Malignant |
N17 | 342 | 10 | M | Lymph node | Diffuse B cell lymphoma of left neck | * | * | * | Malignant |
N18 | 343 | 50 | F | Lymph node | Diffuse B cell lymphoma of right armpit | * | * | * | Malignant |
N19 | 344 | 57 | F | Lymph node | Diffuse B cell lymphoma of right neck | * | * | * | Malignant |
N20 | 345 | 40 | F | Lymph node | Anaplastic large cell lymphoma of left groin | * | * | * | Malignant |
N21 | 346 | 60 | M | Waist | Mucinous liposarcoma of right waist | * | T2bN0M0 | IB | Malignant |
N22 | 347 | 34 | F | Retroperitoneal cavity | Mucinous liposarcoma | * | T2bN0M0 | IB | Malignant |
N23 | 348 | 63 | M | Armpit | Mucinous liposarcoma of left armpit | * | T2bN0M0 | IB | Malignant |
N24 | 349 | 39 | M | Back | Mucinous liposarcoma | * | T2aN0M0 | IB | Malignant |
N25 | 350 | 57 | F | Thigh | Spindle cell type liposarcoma of right thigh | * | T1N0M0 | IA | Malignant |
O1 | 351 | 18 | F | Thyroid gland | Thyroid gland tissue | * | * | * | Normal |
O2 | 352 | 15 | F | Thyroid gland | Thyroid gland tissue | * | * | * | Normal |
O3 | 353 | 50 | M | Thyroid gland | Thyroid gland tissue | * | * | * | Normal |
O4 | 354 | 30 | M | Thyroid gland | Thyroid gland tissue | * | * | * | Normal |
O5 | 355 | 50 | M | Thyroid gland | Thyroid gland tissue | * | * | * | Normal |
O6 | 356 | 47 | M | Lung | Lung tissue | * | * | * | Normal |
O7 | 357 | 41 | F | Lung | Lung tissue | * | * | * | Normal |
O8 | 358 | 15 | F | Lung | Lung tissue | * | * | * | Normal |
O9 | 359 | 47 | M | Lung | Lung tissue | * | * | * | Normal |
O10 | 360 | 24 | M | Lung | Lung tissue | * | * | * | Normal |
O11 | 361 | 19 | F | Skin | Skin tissue of abdominal part | * | * | * | Normal |
O12 | 362 | 38 | M | Skin | Skin tissue | * | * | * | Normal |
O13 | 363 | 28 | M | Skin | Skin tissue of scalp | * | * | * | Normal |
O14 | 364 | 22 | M | Skin | Skin tissue | * | * | * | Normal |
O15 | 365 | 21 | F | Skin | Skin tissue | * | * | * | Normal |
O16 | 366 | 21 | F | Lymph node | Lymph node tissue | * | * | * | Normal |
O17 | 367 | 43 | M | Lymph node | Lymph node tissue | * | * | * | Normal |
O18 | 368 | 30 | M | Lymph node | Lymph node tissue | * | * | * | Normal |
O19 | 369 | 38 | M | Lymph node | Lymph node tissue | * | * | * | Normal |
O20 | 370 | 30 | M | Lymph node | Lymph node tissue | * | * | * | Normal |
O21 | 371 | 40 | M | Skeletal muscle | Skeletal muscle tissue | * | * | * | Normal |
O22 | 372 | 35 | M | Skeletal muscle | Skeletal muscle tissue | * | * | * | Normal |
O23 | 373 | 22 | M | Skeletal muscle | Skeletal muscle tissue | * | * | * | Normal |
O24 | 374 | 40 | M | Skeletal muscle | Skeletal muscle tissue | * | * | * | Normal |
O25 | 375 | 50 | M | Skeletal muscle | Skeletal muscle tissue | * | * | * | Normal |
P1 | 376 | 71 | M | Liver | Hepatocellular carcinoma | 1 | T3N0M0 | III | Malignant |
P2 | 377 | 56 | M | Liver | Hepatocellular carcinoma | 2 | T3N0M0 | III | Malignant |
P3 | 378 | 38 | M | Liver | Hepatocellular carcinoma | 2 | T3N0M0 | III | Malignant |
P4 | 379 | 35 | M | Liver | Hepatocellular carcinoma | 1 | T2N0M0 | II | Malignant |
P5 | 380 | 63 | M | Liver | Hepatocellular carcinoma | 2 | T3N0M0 | III | Malignant |
P6 | 381 | 47 | F | Pancreas | Adenocarcinoma | 1 | T3N0M0 | IIA | Malignant |
P7 | 382 | 60 | M | Pancreas | Adenocarcinoma | 3 | T2N1M0 | IIB | Malignant |
P8 | 383 | 58 | F | Pancreas | Adenocarcinoma | 2 | T4N0M0 | III | Malignant |
P9 | 384 | 68 | F | Pancreas | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant |
P10 | 385 | 56 | F | Pancreas | Adenocarcinoma | 1 | T2N0M0 | IB | Malignant |
P11 | 386 | 51 | M | Kidney | Clear cell carcinoma | 1 | T2N0M0 | II | Malignant |
P12 | 387 | 63 | M | Kidney | Clear cell carcinoma | 1 | T1N0M0 | I | Malignant |
P13 | 388 | 47 | F | Kidney | Clear cell carcinoma | 1 | T2N0M0 | II | Malignant |
P14 | 389 | 72 | F | Kidney | Clear cell carcinoma | 1 | T1N0M0 | I | Malignant |
P15 | 390 | 82 | M | Kidney | Clear cell carcinoma | 1 | T1N0M0 | I | Malignant |
P16 | 391 | 42 | F | Cervix | Squamous cell carcinoma | 1 | T1bN0M0 | IB | Malignant |
P17 | 392 | 42 | F | Cervix | Squamous cell carcinoma | 1 | T2bN0M0 | IIB | Malignant |
P18 | 393 | 56 | F | Cervix | Squamous cell carcinoma | 1 | T2aN0M0 | IIA | Malignant |
P19 | 394 | 50 | F | Cervix | Squamous cell carcinoma | 1 | T2aN0M0 | IIA | Malignant |
P20 | 395 | 55 | F | Cervix | Squamous cell carcinoma | 2 | T1N0M0 | I | Malignant |
P21 | 396 | 48 | M | Esophagus | Squamous cell carcinoma | 2 | T3N1M0 | IIIA | Malignant |
P22 | 397 | 56 | M | Esophagus | Squamous cell carcinoma | 2 | T2N1M0 | IIB | Malignant |
P23 | 398 | 64 | M | Esophagus | Squamous cell carcinoma | 2 | T3N0M0 | IIA | Malignant |
P24 | 399 | 62 | M | Esophagus | Squamous cell carcinoma | 2 | T3N1M0 | IIIA | Malignant |
P25 | 400 | 56 | M | Esophagus | Squamous cell carcinoma | 2 | T3N0M0 | IIA | Malignant |
Q1 | 401 | 60 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant |
Q2 | 402 | 32 | F | Liver | Hepatocellular carcinoma | 2 | T3N0M0 | III | Malignant |
Q3 | 403 | 36 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant |
Q4 | 404 | 49 | M | Liver | Hepatocellular carcinoma | 2 | T3N0M0 | III | Malignant |
Q5 | 405 | 49 | M | Liver | Hepatocellular carcinoma | 2 | T3N0M0 | III | Malignant |
Q6 | 406 | 72 | F | Pancreas | Adenocarcinoma | 1 | T3N0M0 | IIA | Malignant |
Q7 | 407 | 52 | M | Pancreas | Adenocarcinoma | 2 | T3N1M0 | IIB | Malignant |
Q8 | 408 | 42 | M | Pancreas | Adenocarcinoma | 1 | T3N0M0 | IIA | Malignant |
Q9 | 409 | 62 | F | Pancreas | Adenocarcinoma | 1 | T3N0M0 | IIA | Malignant |
Q10 | 410 | 64 | M | Pancreas | Adenocarcinoma | 1 | T3N0M0 | IIA | Malignant |
Q11 | 411 | 69 | M | Kidney | Clear cell carcinoma | 2 | T1N0M0 | I | Malignant |
Q12 | 412 | 63 | M | Kidney | Clear cell carcinoma | 2 | T1N0M0 | I | Malignant |
Q13 | 413 | 54 | M | Kidney | Clear cell carcinoma | 2 | T1N0M0 | I | Malignant |
Q14 | 414 | 47 | M | Kidney | Clear cell carcinoma | 2 | T3aN0M0 | III | Malignant |
Q15 | 415 | 56 | M | Kidney | Clear cell carcinoma | 2 | T1N0M0 | I | Malignant |
Q16 | 416 | 24 | F | Cervix | Squamous cell carcinoma | 2 | T2aN0M0 | IIA | Malignant |
Q17 | 417 | 40 | F | Cervix | Squamous cell carcinoma | 2 | T1N1M0 | IIIC | Malignant |
Q18 | 418 | 44 | F | Cervix | Squamous cell carcinoma | 2 | T1bN0M0 | IB | Malignant |
Q19 | 419 | 32 | F | Cervix | Squamous cell carcinoma | 2 | T1bN0M0 | IB | Malignant |
Q20 | 420 | 41 | F | Cervix | Squamous cell carcinoma | 2 | T2bN0M0 | IIB | Malignant |
Q21 | 421 | 57 | M | Esophagus | Squamous cell carcinoma | 3 | T4N0M0 | IIIA | Malignant |
Q22 | 422 | 57 | M | Esophagus | Squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant |
Q23 | 423 | 66 | M | Esophagus | Squamous cell carcinoma | 3 | T3N0M0 | IIA | Malignant |
Q24 | 424 | 54 | M | Esophagus | Squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant |
Q25 | 425 | 56 | M | Esophagus | Squamous cell carcinoma | 3 | T3N0M0 | IIA | Malignant |
R1 | 426 | 43 | F | Liver | Hepatocellular carcinoma | 2--3 | T4N0M0 | IIIC | Malignant |
R2 | 427 | 48 | M | Liver | Hepatocellular carcinoma | 2--3 | T2N0M0 | II | Malignant |
R3 | 428 | 55 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | III | Malignant |
R4 | 429 | 52 | M | Liver | Hepatocellular carcinoma | 1 | T3N0M0 | III | Malignant |
R5 | 430 | 35 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | III | Malignant |
R6 | 431 | 56 | M | Pancreas | Adenocarcinoma with necrosis | 3 | T2N0M0 | IB | Malignant |
R7 | 432 | 52 | M | Pancreas | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant |
R8 | 433 | 42 | F | Pancreas | Adenocarcinoma | 2 | T3N0M0 | IIA | Malignant |
R9 | 434 | 60 | M | Pancreas | Adenocarcinoma | 2 | T3N0M0 | IIA | Malignant |
R10 | 435 | 57 | F | Pancreas | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant |
R11 | 436 | 40 | M | Kidney | Clear cell carcinoma | 2 | T1N0M0 | I | Malignant |
R12 | 437 | 43 | M | Kidney | Clear cell carcinoma | 2 | T1N0M0 | I | Malignant |
R13 | 438 | 62 | M | Kidney | Clear cell carcinoma | 2 | T1N0M0 | I | Malignant |
R14 | 439 | 59 | M | Kidney | Clear cell carcinoma | 2 | T1N0M0 | I | Malignant |
R15 | 440 | 65 | M | Kidney | Clear cell carcinoma | 2 | T2N0M0 | II | Malignant |
R16 | 441 | 56 | F | Cervix | Squamous cell carcinoma | 2 | T1N1M0 | IIIC | Malignant |
R17 | 442 | 50 | F | Cervix | Squamous cell carcinoma | 2 | T1bN0M0 | IB | Malignant |
R18 | 443 | 39 | F | Cervix | Squamous cell carcinoma | 2 | T1N0M0 | I | Malignant |
R19 | 444 | 43 | F | Cervix | Squamous cell carcinoma | 1 | T1aN0M0 | IA | Malignant |
R20 | 445 | 54 | F | Cervix | Squamous cell carcinoma | 2 | T2bN0M0 | IIB | Malignant |
R21 | 446 | 68 | M | Esophagus | Adenocarcinoma | 3 | T3N1M0 | IIIA | Malignant |
R22 | 447 | 53 | M | Esophagus | Adenocarcinoma | 2 | T2N0M0 | IB | Malignant |
R23 | 448 | 62 | M | Esophagus | Adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant |
R24 | 449 | 56 | M | Esophagus | Adenocarcinoma | 3 | T3N0M0 | IIA | Malignant |
R25 | 450 | 72 | M | Esophagus | Adenocarcinoma | 2 | T2N0M0 | IB | Malignant |
S1 | 451 | 63 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | III | Malignant |
S2 | 452 | 55 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | III | Malignant |
S3 | 453 | 55 | F | Liver | Hepatocellular carcinoma | 1 | T3N0M0 | III | Malignant |
S4 | 454 | 65 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | III | Malignant |
S5 | 455 | 42 | M | Liver | Hepatocellular carcinoma | 3 | T4N0M0 | IIIC | Malignant |
S6 | 456 | 58 | F | Pancreas | Adenocarcinoma | 3 | T3N0M0 | IIA | Malignant |
S7 | 457 | 60 | M | Pancreas | Adenocarcinoma | 1 | T3N0M0 | IIA | Malignant |
S8 | 458 | 64 | M | Pancreas | Adenocarcinoma | 3 | T3N0M0 | IIA | Malignant |
S9 | 459 | 48 | F | Pancreas | Adenocarcinoma | 1 | T3N1M0 | IIB | Malignant |
S10 | 460 | 55 | M | Pancreas | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant |
S11 | 461 | 50 | M | Kidney | Clear cell carcinoma | 2 | T1N0M0 | I | Malignant |
S12 | 462 | 57 | F | Kidney | Clear cell carcinoma | 2 | T1N0M0 | I | Malignant |
S13 | 463 | 80 | M | Kidney | Clear cell carcinoma | 2 | T1N0M0 | I | Malignant |
S14 | 464 | 58 | M | Kidney | Clear cell carcinoma | 3 | T2N1M0 | III | Malignant |
S15 | 465 | 82 | M | Kidney | Clear cell carcinoma | 3 | T1N0M0 | I | Malignant |
S16 | 466 | 37 | F | Cervix | Squamous cell carcinoma | 3 | T1N0M0 | I | Malignant |
S17 | 467 | 42 | F | Cervix | Squamous cell carcinoma | 3 | T1N1M0 | IIIC | Malignant |
S18 | 468 | 44 | F | Cervix | Squamous cell carcinoma | 3 | T1bN0M0 | IB | Malignant |
S19 | 469 | 60 | F | Cervix | Squamous cell carcinoma | 3 | T1bN0M0 | IB | Malignant |
S20 | 470 | 54 | F | Cervix | Squamous cell carcinoma | 3 | T1N0M0 | I | Malignant |
S21 | 471 | 63 | M | Esophagus | Adenocarcinoma | 3 | T3N0M0 | IIA | Malignant |
S22 | 472 | 66 | M | Esophagus | Adenocarcinoma | 3 | T4N1M0 | IIIC | Malignant |
S23 | 473 | 65 | M | Esophagus | Adenocarcinoma | 3 | T4N1M0 | IIIC | Malignant |
S24 | 474 | 60 | F | Esophagus | Adenocarcinoma | 2 | T3N0M0 | IIA | Malignant |
S25 | 475 | 58 | F | Esophagus | Adenocarcinoma | 3 | T4N0M0 | IIIA | Malignant |
T1 | 476 | 50 | F | Liver | Liver tissue | * | * | * | Normal |
T2 | 477 | 43 | M | Liver | Liver tissue | * | * | * | Normal |
T3 | 478 | 45 | M | Liver | Liver tissue | * | * | * | Normal |
T4 | 479 | 16 | M | Liver | Liver tissue | * | * | * | Normal |
T5 | 480 | 40 | M | Liver | Liver tissue | * | * | * | Normal |
T6 | 481 | 21 | F | Pancreas | Pancreas tissue | * | * | * | Normal |
T7 | 482 | 50 | M | Pancreas | Pancreas tissue | * | * | * | Normal |
T8 | 483 | 47 | M | Pancreas | Pancreas tissue | * | * | * | Normal |
T9 | 484 | 35 | M | Pancreas | Pancreas tissue | * | * | * | Normal |
T10 | 485 | 21 | F | Pancreas | Pancreas tissue | * | * | * | Normal |
T11 | 486 | 47 | M | Kidney | Kidney tissue | * | * | * | Normal |
T12 | 487 | 50 | M | Kidney | Kidney tissue | * | * | * | Normal |
T13 | 488 | 16 | M | Kidney | Kidney tissue | * | * | * | Normal |
T14 | 489 | 48 | M | Kidney | Adjacent normal kidney tissue | * | * | * | NAT |
T15 | 490 | 47 | M | Kidney | Kidney tissue | * | * | * | Normal |
T16 | 491 | 40 | F | Cervix | Adjacent normal cervix tissue | * | * | * | NAT |
T17 | 492 | 72 | F | Cervix | Adjacent normal cervix tissue | * | * | * | NAT |
T18 | 493 | 50 | F | Cervix | Cervical canal tissue | * | * | * | Normal |
T19 | 494 | 35 | F | Cervix | Adjacent normal cervix canal tissue | * | * | * | NAT |
T20 | 495 | 50 | F | Cervix | Adjacent normal cervix tissue | * | * | * | NAT |
T21 | 496 | 16 | M | Esophagus | Esophagus tissue | * | * | * | Normal |
T22 | 497 | 28 | M | Esophagus | Esophagus tissue | * | * | * | Normal |
T23 | 498 | 42 | F | Esophagus | Esophagus tissue | * | * | * | Normal |
T24 | 499 | 43 | M | Esophagus | Esophagus tissue | * | * | * | Normal |
T25 | 500 | 28 | M | Esophagus | Esophagus tissue | * | * | * | Normal |
Tissue Marker |